Asialoganglioside enhances the efficiency of gene transfection mediated by cationic liposomes with a cationic cholesterol derivative

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 9, 2003, Pages 1306-1310

  Noguchi, Shoichiro ^a   Hirashima, Naohide ^a   Nakanishi, Mamoru ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Antisense oligonucleotide; Asialoganglioside; Bcl 2; Cationic cholesterol; Gene transfection; Sialic acid

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CHOLESTEROL DERIVATIVE; GANGLIOTETRAOSYLCERAMIDE; LIPOSOME; LUCIFERASE; PROTEIN BCL 2; SIALIC ACID; ANTISENSE OLIGONUCLEOTIDE; CATION; CHOLESTEROL; DRUG CARRIER; GALACTOSE; GLYCOSPHINGOLIPID;

APOPTOSIS; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAMMAL CELL; PLASMID; WESTERN BLOTTING; CHEMISTRY; DRUG EFFECT; GENE TRANSFER; GENETICS; HELA CELL; PROTO ONCOGENE; TUMOR CELL LINE;

APOPTOSIS; BLOTTING, WESTERN; CATIONS; CELL LINE, TUMOR; CHOLESTEROL; DRUG CARRIERS; GALACTOSE; GENE TRANSFER TECHNIQUES; GENES, BCL-2; GLYCOSPHINGOLIPIDS; HELA CELLS; HUMANS; LIPOSOMES; LUCIFERASES; OLIGONUCLEOTIDES, ANTISENSE; TRANSFECTION;

EID: 2142808702     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.26.1306     Document Type: Article

References (25)

1. Hope M. J., Mui B., Ansell S., Ahkong Q. F., Mol. Membr. Biol., 15, 1-14 (1998).
2. Li S., Huang L., Gene Ther., 7, 31-34 (2000).
3. Smith J. G., Walzem R. L., German J. B., Biochim. Biophys. Acta, 1154, 327-340 (1993).
4. Felgner P. L., Gadek T. R., Holm M., Roman R., Chan H. W., Wenz M., Northrop J. P., Ringold G. M., Danielsen M., Proc. Natl. Acad. Sci. U.S.A., 84, 7413-7417 (1987).
5. Gao X., Huang L., Biochem. Biophys. Res. Commun., 179, 280-285 (1991).
6. Okayama R., Noji M., Nakanishi M., FEBS Lett., 408, 232-234 (1997).
7. Fujiwara T., Hasegawa S., Hirashima N., Nakanishi M., Ohwada T., Biochim. Biophys. Acta, 1468, 396-402 (2001).
8. Garcia-Chaumont C., Seksek O., Grzybowska J., Borowski E., Bolard J., Pharmacol. Ther., 87, 255-277 (2000).
9. Zabner J., Fasbender A. J., Moninger T., Poellinger K. A., Welsh M. J., J. Biol. Chem., 279, 18997-19007 (1995).
10. Noguchi A., Furuno T., Kawaura C., Nakanishi M., FEBS Lett., 433, 169-173 (1998).
11. Hasegawa S., Hirashima N., Nakanishi M., Gene Ther., 8, 1669-1673 (2001).
12. Pollard H., Remy J. S., Loussouarn G., Demolombe S., Behr J. P., Escande D., J. Biol. Chem., 273, 7507-7511 (1988).
13. Kamiya H., Yamazaki J., Harashima H., Gene Ther., 9, 1500-1507 (2002).
14. Zanta M. A., Belguise-Valladier P., Behr J. P., Proc. Natl. Acad. Sci. U.S.A., 96, 91-96 (1999).
15. Remy J., Abdallah B., Zanta M. A., Boussif O., Behr J., Demeneix B., Adv. Drug. Deliv. Rev., 30, 85-95 (1998).
16. Simoes S., Slepushkin V., Pires P., Gaspar R., de Lima M. P., Duzgunes N., Gene Ther., 6, 1798-1807 (1999).
17. Inoh Y., Kitamoto D., Hirashima N., Nakanishi M., Biochem. Biophys. Res. Commun., 289, 57-61 (2001).
18. Noguchi A., Hirashima N., Furuno T., Nakanishi M., Neurosci. Lett., 325, 29-32 (2001).
19. Kawaura C., Hasegawa S., Hirashima N., Nakanishi M., Biol. Pharm. Bull., 23, 778-780 (2000).
20. Crespo J., Blaya C., Crespo A., Alino S. F., Biochem. Pharmacol., 51, 1309-1314 (1996).
21. Weiss P., Ashwell G., Prog. Clin. Biol. Res., 300, 169-184 (1989).
22. Noguchi S., Hirashima N., Furuno T., Nakanishi M., J. Control. Release, 88, 313-320 (2003).
23. Sherwood S. W., Methods Cell Biol., 46, 77-97 (1995).
24. Surolina A., Bachhawat B. K., Biochim. Biophys. Acta, 497, 760-765 (1977).
25. Saqr H. E., Pearl D. K., Yates A. J., J. Neurochem., 61, 395-411 (1993).